CHF
<ѻý class="page-description">More in CHF
Recent developments of interest in cardiovascular medicine
Researchers try to address challenge of distinguishing HCM from other cardiomyopathies
Evoque device helped outcomes in severe tricuspid regurgitation, with some safety caveats
Recent developments of interest in cardiovascular medicine
Anti-mineralocorticoid agent reduced albuminuria, but not eGFR-based kidney outcome
Larger pool of TAVR candidates suggested by EARLY TAVR trial results
Recent developments of interest in cardiovascular medicine
Recent developments of interest in cardiovascular medicine
Effectiveness of this personalized approach now under investigation
Panelists acknowledge difficulty generating stronger data in ultra-rare disease
Agency appears unswayed by mitochondria-targeting drug for rare cardioskeletal disease
Recent developments of interest in cardiovascular medicine
Benefit in symptoms, functional outcomes remains to be seen for HU6
Recent developments of interest in cardiovascular medicine
